uracil has been researched along with Biliary Tract Cancer in 13 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to clarify the safety and efficacy of combination chemotherapy of uracil-tegafur (UFT) and doxorubicin (UFD regimen), and to identify the prognostic factors in patients with unresectable advanced biliary tract cancer who received systemic chemotherapy." | 9.14 | A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer. ( Boku, N; Funakoshi, A; Furuse, J; Nagase, M; Ohkawa, S; Okusaka, T; Sato, T; Yamaguchi, T; Yamao, K, 2009) |
| "Standard chemotherapy for advanced biliary tract cancer has not been established." | 6.72 | Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer. ( Funakoshi, A; Furuse, J; Horikawa, Y; Ikeda, M; Ishii, H; Mizuno, N; Morizane, C; Nagase, M; Nakachi, K; Okusaka, T; Ueno, H; Yamao, K, 2006) |
| "The purpose of this study was to clarify the safety and efficacy of combination chemotherapy of uracil-tegafur (UFT) and doxorubicin (UFD regimen), and to identify the prognostic factors in patients with unresectable advanced biliary tract cancer who received systemic chemotherapy." | 5.14 | A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer. ( Boku, N; Funakoshi, A; Furuse, J; Nagase, M; Ohkawa, S; Okusaka, T; Sato, T; Yamaguchi, T; Yamao, K, 2009) |
| "Eniluracil is an effective inactivator of dihydropyrimidine dehydrogenase (DPD)." | 2.72 | A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract. ( Cohen, DP; Czito, BG; Fernando, N; Hong, TJ; Hurwitz, HI; Lee, CG; Lockhart, AC; Morse, MA; Pappas, TN; Petros, WP; Tyler, DS; Yu, D, 2006) |
| "Standard chemotherapy for advanced biliary tract cancer has not been established." | 2.72 | Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer. ( Funakoshi, A; Furuse, J; Horikawa, Y; Ikeda, M; Ishii, H; Mizuno, N; Morizane, C; Nagase, M; Nakachi, K; Okusaka, T; Ueno, H; Yamao, K, 2006) |
| "Uracil-tegafur (UFT) has been reported to have broad antitumor activity in a variety of malignancies." | 2.71 | A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Morizane, C; Okusaka, T; Ueno, H, 2005) |
| "In advanced biliary tract cancer, overall survival of elderly patients receiving palliative chemotherapy is comparable with that of non-elderly patients." | 1.40 | Comparative outcomes of elderly and non-elderly patients receiving first-line palliative chemotherapy for advanced biliary tract cancer. ( Ajiki, T; Awane, M; Furuyama, H; Ikai, I; Ikezawa, K; Ioka, T; Kanai, M; Kou, T; Kume, M; Kuroda, N; Miyamoto, A; Nagano, H; Ochiai, T; Ogawa, M; Taira, K; Takeda, Y; Takemura, S; Terajima, H; Toyokawa, H; Tsukamoto, T; Yazumi, S, 2014) |
| "Thirty four patients with advanced gastric cancer (GC), colon cancer (CC) biliary tract cancer (BC) and pancreatic cancer (PC) were treated with a combined chemotherapy of UFT with ADM (UFT-A), or UFT with ADM and CDDP (UFT-AC)." | 1.28 | [Combination chemotherapy of UFT with adriamycin (ADM) and cisplatin (CDDP) for advanced gastrointestinal cancer]. ( Koda, K; Kure, T; Matsunaga, T; Miyazaki, E; Morii, K; Morita, K; Nakajima, K; Nakazawa, O; Terada, S; Tsuji, Y, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kou, T | 1 |
| Kanai, M | 1 |
| Ikezawa, K | 1 |
| Ajiki, T | 1 |
| Tsukamoto, T | 1 |
| Toyokawa, H | 1 |
| Yazumi, S | 1 |
| Terajima, H | 1 |
| Furuyama, H | 1 |
| Nagano, H | 1 |
| Ikai, I | 1 |
| Kuroda, N | 1 |
| Awane, M | 1 |
| Ochiai, T | 1 |
| Takemura, S | 1 |
| Miyamoto, A | 1 |
| Kume, M | 1 |
| Ogawa, M | 1 |
| Takeda, Y | 1 |
| Taira, K | 1 |
| Ioka, T | 1 |
| Kim, MJ | 1 |
| Oh, DY | 1 |
| Lee, SH | 1 |
| Kim, DW | 1 |
| Im, SA | 1 |
| Kim, TY | 1 |
| Heo, DS | 1 |
| Bang, YJ | 1 |
| Furuse, J | 3 |
| Okusaka, T | 4 |
| Ohkawa, S | 1 |
| Nagase, M | 2 |
| Funakoshi, A | 2 |
| Boku, N | 1 |
| Yamao, K | 2 |
| Yamaguchi, T | 1 |
| Sato, T | 1 |
| Chen, JS | 1 |
| Yang, TS | 1 |
| Lin, YC | 1 |
| Jan, YY | 1 |
| WEISS, AJ | 1 |
| JACKSON, L | 1 |
| Park, KH | 1 |
| Choi, IK | 1 |
| Kim, SJ | 1 |
| Oh, SC | 1 |
| Seo, JH | 1 |
| Choi, CW | 1 |
| Kim, BS | 1 |
| Shin, SW | 1 |
| Kim, YH | 1 |
| Kim, JS | 1 |
| Ikeda, M | 3 |
| Ueno, H | 3 |
| Morizane, C | 3 |
| Ishii, H | 2 |
| Czito, BG | 1 |
| Hong, TJ | 1 |
| Cohen, DP | 1 |
| Petros, WP | 1 |
| Tyler, DS | 1 |
| Pappas, TN | 1 |
| Yu, D | 1 |
| Lee, CG | 1 |
| Lockhart, AC | 1 |
| Morse, MA | 1 |
| Fernando, N | 1 |
| Hurwitz, HI | 1 |
| Nakachi, K | 1 |
| Horikawa, Y | 1 |
| Mizuno, N | 1 |
| Koda, K | 2 |
| Nakazawa, O | 2 |
| Morita, K | 2 |
| Kure, T | 2 |
| Terada, S | 2 |
| Matsunaga, T | 1 |
| Tsuji, Y | 1 |
| Miyazaki, E | 1 |
| Nakajima, K | 1 |
| Morii, K | 1 |
| Tomita, T | 1 |
| Tajima, T | 1 |
| Ishibashi, M | 1 |
| Tagaya, N | 1 |
| Aoki, H | 1 |
| Itoh, S | 1 |
| Kadowaki, A | 1 |
| Kogure, H | 1 |
| Tajima, Y | 1 |
| Arai, R | 1 |
| Hirayama, M | 1 |
| Terui, T | 1 |
| Fukushi, A | 1 |
| Yoshizaki, N | 1 |
1 review available for uracil and Biliary Tract Cancer
| Article | Year |
|---|---|
[5 -fluoropyrimidines for treatment of biliary tract cancers].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cape | 2006 |
6 trials available for uracil and Biliary Tract Cancer
| Article | Year |
|---|---|
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Topics: Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Du | 2009 |
A phase II trial of tegafur-uracil plus leucovorin (LV) in the treatment of advanced biliary tract carcinomas.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neo | 2003 |
The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Epi | 2005 |
A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Biliary Tract Neoplasms; Drug Adm | 2005 |
A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Combined Modality The | 2006 |
Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; | 2006 |
6 other studies available for uracil and Biliary Tract Cancer
| Article | Year |
|---|---|
Comparative outcomes of elderly and non-elderly patients receiving first-line palliative chemotherapy for advanced biliary tract cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemothe | 2014 |
Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neopla | 2008 |
The effect of 5-fluorouracil upon carcinomas of the gastrointestinal tract and related organs.
Topics: Biliary Tract; Biliary Tract Neoplasms; Digestive System Neoplasms; Fluorouracil; Gastrointestinal T | 1961 |
[Combination chemotherapy of UFT with adriamycin (ADM) and cisplatin (CDDP) for advanced gastrointestinal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Col | 1990 |
[Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile; Biliary Tract Neoplasms; Cholestasis; Fe | 1989 |
[Combination chemotherapy of UFT with adriamycin in advanced gastrointestinal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Colonic Neopla | 1987 |